Publications

• Early Detection of Alzheimer's Disease-Related Pathology Using a Multi-Disease Diagnostic Platform Employing Autoantibodies as Blood-Based Biomarkers. Journal of Alzheimer's Disease 92 (2023) 1077–1091. Full article in PDF

​

• Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-β1-42 and Key Cell Surface Proteins During Alzheimer's Disease Pathogenesis Journal of Alzheimer's Disease 74 (2020) 345–361.
  Full article in PDF

​

• ​​The origin and nature of the complex autoantibody profile in cerebrospinal fluid. Brain, Behavior, & Immunity - Health 2 (2020) 100032. Full article in PDF​

​

• Detection of early-stage Alzheimer's pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients. ​PLoS One (2019) Vol 14, Issue 11, e0225178. Full article in PDF

​

• Autoantibodies as diagnostic biomarkers for the detection and subtyping of Multiple Sclerosis. ​Journal of Neuroimmunology 309 (2017) 51-57. Full article in PDF

​

• ​Detection of Alzheimer’s disease at Mild Cognitive Impairment and disease progression using autoantibodies as blood-based biomarkers. ​Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring  3 (2016) 51-62. Full article in PDF

​

• ​Serum autoantibodies as biomarkers for Parkinson’s disease: background and utility. ​AIMS Medical Science 2015 Vol 2 (4): 316 - 325. Full Article in PDF

​

• ​Sevoflurane and Isoflurane induce structural changes in brain vascular endothelial cells and increase blood-brain barrier permeability: Possible link to postoperative delirium and cognitive decline. ​Brain Research September 16, 2015 Vol 1620, Pages 29-41.

​

• ​​Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson's disease. Immunology Letters 168 (2015) 80-88. Full article in PDF

​

• ​​Utility of autoantibodies as biomarkers for diagnosis and staging of neurodegenerative disease. International Review of Neurobiology Vol 122 (2015) 1-51.​

​

• Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease. ​PLoS One (2013) Vol 8, Issue 4, e60726. Full article in PDF

​

• ​Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition: beneficial effects of the LpPLA2 inhibitor darapladib. Journal of Alzheimer's Disease 2013; 35(1):179-98.

​

• ​​Neuronal PAD4 expression and protein citrullination: possible role in production of autoantibodies associated with neurodegenerative disease. Journal of Autoimmunity 2012 Jun;38(4):369-80.

​

• ​Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera. ​PLoS One (2012) Vol 7, Issue 2, e32383. Full article in PDF

​

• ​Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera. PLoS One (2011) Vol 6, Issue 8, e23112. Full article in PDF​